EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the companys board of directors granted four new employees restricted stock units to acquire 44,500 shares of the companys…
More News
Bitcoin ETFs attract $240M despite crypto market downturn
April 11, 2026
Bitcoin nears $73K again as ETH and HYPE push higher
April 11, 2026